0001628804-17-000002.txt : 20170526 0001628804-17-000002.hdr.sgml : 20170526 20170526160602 ACCESSION NUMBER: 0001628804-17-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170526 DATE AS OF CHANGE: 20170526 EFFECTIVENESS DATE: 20170526 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Next Frontier Biosciences, LLC CENTRAL INDEX KEY: 0001628804 IRS NUMBER: 464797759 STATE OF INCORPORATION: CO FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-284036 FILM NUMBER: 17873968 BUSINESS ADDRESS: STREET 1: 4156 15TH STREET CITY: BOULDER STATE: CO ZIP: 80304 BUSINESS PHONE: 303-550-3133 MAIL ADDRESS: STREET 1: 4156 15TH STREET CITY: BOULDER STATE: CO ZIP: 80304 FORMER COMPANY: FORMER CONFORMED NAME: TM Delivery Systems, LLC DATE OF NAME CHANGE: 20141222 D/A 1 primary_doc.xml X0707 D/A LIVE 0001628804 Next Frontier Biosciences, LLC 4156 15TH STREET BOULDER CO COLORADO 80304 303-550-3133 COLORADO TM Delivery Systems, LLC Limited Liability Company true 2014 Marc Graboyes 4156 15th Street Boulder CO COLORADO 80304 Executive Officer Director President, Chief Executive Officer, Treasurer and Secretary Paul Johnson 12020 211th Place SE Snohomish WA WASHINGTON 98296 Executive Officer Director Executive Vice President, Chief Scientific Officer Other Health Care Decline to Disclose 06b true 0001628804-17-000001 2017-03-20 false true false 0 Norman Jones 6322035 LoHi Securities 36402 c/o Catalyst Partners, LLC 700 Louisiana Street, Suite 3950 Houston TX TEXAS 77002 CA CALIFORNIA CO COLORADO NM NEW MEXICO NY NEW YORK TX TEXAS false 3000000 1785119 1214881 Offer and Sale of Series A Preferred Units and Conversion of Simple Agreements for Future Equity (SAFEs) into Series A Preferred Units false 14 120000 true 0 Contingent fees subject to investment by referred investors 0 false Next Frontier Biosciences, LLC Marc Graboyes Marc Graboyes Manager 2017-05-24